Health Care·Health Care Equipment·$17.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.08 | N/A | -1.33% |
management commentary, guidance changes, and full analysis available with Pro.
| -1.33% |
Tone: Defensive
Management expressed concerns about market conditions affecting performance. They emphasized their commitment to improving operational efficiency.
We are navigating a challenging market environment.
Our focus remains on operational efficiency and innovation.
Zimmer Biomet's earnings report shows a slight miss on EPS, which contributed to a 2.53% decline in stock price. The company is facing challenges in the market, and management's cautious tone suggests that investors should be prepared for potential headwinds ahead. Without updated guidance, uncertainty remains about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
HALLIBURTON CO
Jul 24, 2017